Caspases are a family of cysteine-proteases that are activated during renal injury and are implicated in the pathogenesis of acute renal failure (ARF). [1] [2] [3] [4] Caspase 9 is activated after mitochondrial release of proapoptotic molecules in response to intrinsic signals such as hypoxia, reactive species, ceramide, and growth factor deprivation. 5 On the other hand, caspase 8 is activated after interaction of tumor necrosis factor alpha (TNF-a) and FAS ligand with cellular membrane death receptors. Both pathways activate effectors caspases 3, 6, and 7 that target several cytosolic and nuclear substrates executing the process of apoptosis. 5 Other members of caspase family such as caspases 1, 4, and 5 are not primarily involved in apoptosis, but convert precursors of the inflammatory cytokines interleukin (IL)-1b and IL-18 to active forms 6, 7 and may be relevant in the recruitment and infiltration of leukocytes in the renal parenchyma after renal injury. 1, 8, 9 Furthermore, there is evidence that caspases exert important functions beyond apoptosis and inflammation, including the control of cell cycle progression. 10 Glycerol-induced ARF (Gly-ARF) in rodents is mediated by renal ischemia and myoglobin nephrotoxicity. 11, 12 The release of catalytic iron 13, 14 or the redox cycle of the myoglobin heme 15 induces an oxidative stress and lipid peroxidation of the proximal tubular cell resulting in tubular necrosis in the cortical area. The role of apoptosis and inflammation has not been evaluated yet in the pathogenesis of Gly-ARF. As reactive species can trigger apoptosis through the mitochondrial pathway 16 and inflammation through activation of the transcription factor nuclear factor-kB, 17 it is possible that these mechanisms are relevant in this model.
The aim of this study is to evaluate the importance of the caspases in cell injury, inflammation and tubular regeneration in Gly-ARF. The role of caspases will be addressed through the administration of caspase inhibitors. evaluation through creatinine clearance showed that the protection was partial, since the creatinine clearance of Z-VAD -FMK treated rats was significantly higher than untreated rats, but lower than the observed in controls.
Tubular cell death. The histological examination of the kidneys by optical microscopy showed severe cortical acute tubular necrosis (ATN) in Gly-ARF. The broad pattern of tubular necrosis in this model allowed a quantitative analysis of totally necrotic and denuded tubules per high-power field (HPF Â 400). This objective analysis showed that the Z-VAD-FMK treatment significantly reduced the prevalence of ATN at 24 h ( Figure 1 ).
As the role of apoptotic cell death had not been described yet in this model, we initially looked for transferase-mediated deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling (TUNEL) positive cells at different moments after induction of Gly-ARF. We observed a significant increase in TUNEL positive tubular cells at 6 h in the medullar zone. In later evaluations at 12 and 24 h, the amount of TUNEL positive cells in renal medulla did not differ from control (Figure 2a ). In the renal cortex, there were few TUNEL positive cells that were unchanged by Gly-ARF (control: 0.1570.05, Gly-ARF 6 h: 0.370.16, Gly-ARF 12 h: 0.1470.05, and Gly-ARF 24 h: 0.1070.05, NS). The treatment with Z-VAD-FMK reduced the expression of medullar TUNEL positive cells to a level similar to control group (Figure 2b) .
Inflammation. The sequential analysis of leukocytes accumulated in the kidney tissue is depicted in Table 2 . We observed a significant and progressive increase in the number of macrophages (anti-equine dermal-1 positive cells) present in the renal interstitium, mainly in the outer medulla, during the period of observation (6-120 h). The Z-VAD-FMK treatment reduced the macrophage infiltration at 24 h. T lymphocytes (anti-MSA10P positive cells) were frequent in controls as well as in Gly-ARF rats, mainly in cortex and outer medulla interstitium. The differences observed during the course of Gly-ARF and after Z-VAD-FMK treatment were not significant.
The kidney tissue expression of IL-1b and IL-18 was evaluated by immunohistochemistry. IL-1b was expressed in tubule cells predominantly in the renal cortex, whereas IL-18 was found expressed in tubule cell both in cortex and outer medulla ( Figure 3 ). The computer assisted semiquantitative analysis (Table 3) showed that Gly-ARF had increased expression of IL-1b and unchanged expression of IL-18. The Z-VAD-FMK administration had no influence in these interleukins immunostaining. However, the antibodies recognize both the precursor (35 kDa for IL-1b and 24 kDa for IL-18) and the mature form (17 kDa for IL-1b and 18 kDa for IL-18), and to evaluate the active form expression we performed Western blotting for both cytokines (Figure 4) . The Western blotting showed that IL-1b and IL-18 active forms were expressed in Gly-ARF, but were absent in Gly-ARF treated with Z-VAD-FMK.
Cell cycle. The tubular cell proliferation evaluated by 5-bromo-2 0 -deoxyuridineb (BrdU) incorporation was intense both in the renal cortex and renal medulla 48 h after Gly-ARF. The Z-VAD-FMK administration to Gly-ARF rats had no significant influence on tubular cell proliferation ( Figure 5 ).
The expression of the protein p27 kip , a negative regulator of cell cycle, was clearly detected in the renal cortex of control rats (Western blot) and disappeared in Gly-ARF. The administration of Z-VAD-FMK did not restore the protein p27 kip expression ( Figure 6 ).
Selective caspases inhibition
The selectivity of peptide-based inhibitors used in this study had already been determined in vitro using specific substrates and recombinant human caspases 1-10. 18 The only potent inhibitor of effector caspases (3 and 7) was Ac-DEVD-CHO, whereas caspases 1, 4, and 5 were inactivated preferentially by Ac-YVAD-CHO and also partially by Ac-DEVD-CHO. As effector caspases are not inhibited by Ac-YVAD-CHO, the 'selective' inhibitors may discriminate the preferential role of apoptotic or inflammatory caspases in the pathogenic process. To ease the comprehension of the text, the selective inhibitors will be referred as caspase-1 (Ac-YVAD-CHO) and caspase-3 inhibitors (Ac-DEVD-CHO). The number of positive anti-ED1 cells (macrophages) increased progressively after Gly-ARF both in cortical and medullar interstitium, and the Z-VAD-FMK administration significantly reduced this increase at 24 h. The anti-MS010P positive cells (T lymphocytes) did not show significant variations after Gly-ARF. Gly-ARF: glycerol-induced acute renal failure; Z-VAD-FMK: pan-caspase inhibitor administered concomitant to glycerol; ED, equine dermal. Digital images acquired by video microscopy using KS 300 Imaging System, Zeiss were marked with gridlines 10 Â 10. Data regarding selective caspase inhibition are depicted in Table 4 . The higher dose of glycerol (7 ml/kg) used in this experiment resulted in a more severe renal impairment and tubular injury, mainly tubular apoptosis at 24 h. All caspases inhibitors attenuated the renal function impairment evaluated by serum urea and creatinine. The tubular injury (cortical necrosis and medullar apoptosis) was reduced in groups treated with pan-caspase and caspase-3 inhibitors, whereas caspase-1 inhibitor failed to reduce tubular injury. The macrophage infiltration was attenuated by all treatments.
General caspases inhibition in the course of Gly-ARF
The administration of Z-VAD-FMK 12 h after the induction of Gly-ARF (5 ml/kg) failed to protect the renal function or injury (Table 5 ). Gly-ARF rats treated with Z-VAD-FMK or untreated showed significant and similar reduction in the creatinine clearance at 48 h and similar degree of ATN.
DISCUSSION
Gly-ARF rats showed intense cortical ATN and significant increase in the number of apoptotic tubular cells in the outer medulla. TUNEL positive cells appeared very early and peaked 6 h after Gly-ARF. The administration of pan-caspase or selective caspases inhibitors concomitant to glycerol attenuated the Gly-ARF in all groups. Delayed treatment (12 h) was no longer able to protect the kidneys. Caspases 3 and 7 are the main effectors of apoptosis and pan-caspase and caspase-3 inhibitors significantly reduced the development of apoptosis in our experiments. Pan-caspase and caspase-3 inhibitors also reduced the development of ATN. Although the role of caspases is not clear in the necrosis process, it was not surprising that caspase inhibitors treatment attenuated ATN, since this finding had already been described in previous studies in experimental ARF, 9, [19] [20] [21] and in one study using proximal tubules in vitro. 2 In our study, it was noteworthy the reduction in tubular necrosis in rats treated with caspase-3 inhibitor. Caspase-3 can cleave adherent junctions proteins and dismantle cell-cell contact 22 as well increase calpain activity and cleavage of cell-matrix adhesion molecules. 23, 24 These data suggest that caspase-3 may reduce proximal tubular cell adhesion causing cell detachment and desquamation that may contribute to ATN histological picture in Gly-ARF.
Caspase-1 inhibition attenuated Gly-ARF despite unchanged tubular injury. This finding suggests that caspase-1 inhibition has a favorable effect on glomerular hemodynamics in Gly-ARF. Increased afferent resistance and consequent reduction in the glomerular capillary hydraulic pressure are the main hemodynamic parameters associated with the reduced glomerular filtration rate in established Gly-ARF. 25 The endotoxemic-ARF induced by LPS injection in rats is also characterized by severe renal vasoconstriction. 26 Wang et al. 27 induced LPS-ARF in caspase-1 deficient mice and compared with wild-type controls. Their findings were quite similar to caspase-1 inhibition in our study, with protection of the renal function in knockout mice that was not associated with reduced tubular necrosis or apoptosis. In a recent paper, Tiwari et al. 28 using intravital videomicroscopy showed that pan-caspase inhibition improved cortical peritubular blood flow in LPS-ARF mice. This is direct evidence that caspases are involved in the disruption of cortical microvascular flow in LPS-ARF. IL-1b stimulates the biosynthesis of lipid vasoactive mediators; 29, 30 therefore, the reduced conversion to active IL-1b could reduce vasoconstriction and improve glomerular filtration in ARF.
We have previously shown that neutrophil infiltration in the kidneys is not relevant in Gly-ARF. 31 Here, we focused in the infiltration of mononuclear leukocytes. We observed frequent T lymphocytes in the renal cortex both in controls and in Gly-ARF rats. There was a trend to increase medullar T lymphocytes in untreated Gly-ARF, but this finding was not significant. A pathogenic role for T lymphocytes is well established in renal ischemia/reperfusion injury. [32] [33] [34] [35] On the other hand, an increase in the number of macrophages in the renal parenchyma, mainly in the outer medulla, was remarkable in Gly-ARF. Injured tubules release inflammatory cytokines and chemokynes that stimulate leukocytes recruitment, adhesion to endothelial and epithelial receptors, and infiltration in the renal tissue. 1, [36] [37] [38] [39] In this study, we observed increased tubular expression of IL-1b in Gly-ARF. The Z-VAD-FMK treatment abolished the expression of mature IL-1b and IL-18, and reduced the infiltration of macrophages in the kidney, particularly in the milder form of Gly-ARF (5 ml/kg). The role of macrophages in renal injury is heterogeneous and dependent on predominant activating signal. 40 The proinflammatory activation state results in release of reactive oxygen species and aggravates tubular injury. 41 There is now compelling evidence that macrophages are also able to downregulate inflammation and promote tissue repair. 42 A pathogenic role for macrophages infiltration in ARF has been supported by recent study in which macrophage depletion reduced ischemia/reperfusion injury. 43 The kinetics of macrophages in our study showed progressive accumulation in the kidneys even 120 h after induction of Gly-ARF. At this point, most of the tubular injury had been repaired and many regenerating tubules were surrounded by macrophages in the renal cortex. The intense prevalence of macrophages at this stage suggests a reversion from pro-inflammatory to a reparative state of activation.
There are evidences that caspase-3 can regulate cell cycle progression cleaving several negative regulators of cell cycle such as Wee1, p21 Waf1 , and p27 Kip1 . [44] [45] [46] Caspase 8 À/À mice exhibited impaired heart muscle development and impaired hematopoietic colony-forming activity, 47, 48 and in a rat model of polycystic kidney disease the caspase inhibition decreased proliferation on cystic and noncystic tubules. 49 As tubular regeneration is a fundamental step on renal recovery after ATN, we evaluated the effect of Z-VAD-FMK on tubular cell proliferation 48 h after Gly-ARF. At this point, the BrdU labeling showed intense proliferative activity both in the cortex and in the outer medulla. This response was well preserved in Z-VAD-FMK treated rats, despite the fact that this group showed initially less cellular death. We also evaluated the expression of p27 Kip1 . This protein was clearly expressed in control rats and absent in kidney homogenates 24 h after induction of Gly-ARF. The Z-VAD-FMK treated rats also did not express p27 Kip1 , demonstrating that caspases are not involved in the regulation of p27
Kip1 expression in Gly-ARF.
In conclusion, caspases have an important role in the pathogenesis of Gly-ARF. The caspases system inhibition reduced tubular injury, inflammation, and preserved glomerular filtration. The selective approach revealed some details of the mechanisms of protection. Caspase 3 and 7 are responsible for most of the caspase-dependent tubular apoptosis, but also may participate in the process of necrosis or detachment of proximal tubular cells. A possible favorable glomerular hemodynamic response was observed after caspase-1 inhibition. These new possibilities expand the postulated pathogenic mechanism considered relevant in the caspases involvement in ARF. Finally, we have shown that the tubular regeneration is not dependent on the activity of caspases.
MATERIALS AND METHODS Induction of glycerol ARF and caspase inhibitors treatment
Male Wistar-Hannover rats (220-260 g) were provided by Central Biotery from our Institution. The experiments described here were performed in accordance with the guidelines established by the Brazilian College for Animal Experimentation. Gly-ARF was induced after overnight fast by single intramuscular injection of 50% glycerol divided into both lower hind limbs. Controls received saline intramuscular injection. Rats were treated with the following caspase inhibitors peptides (Alexis Biochemicals, San Diego, CA, USA): general or pan-caspase inhibitor Z-Val-Ala-DL-Asp-Fluoromethylketone (Z-VAD-FMK), Caspase-1 inhibitor Ac-Tyr-Val-AlaAsp-CHO (Ac-YVAD-CHO) and Caspases 3 and 7 inhibitor Ac-Asp-Glu-Val-Asp-CHO (Ac-DEVD-CHO), or vehicle (DMSO 1%). In the first series of experiments, we evaluated the participation of the family of caspases in the pathophysiology of Gly-ARF. With this purpose, a milder form of Gly-ARF was induced (glycerol 5 ml/kg) and the pan-caspase inhibitor (4 mg/kg i.p.) was injected immediately after glycerol injection. In a subsequent series of experiments, the specific role of proapoptotic and proinflammatory caspases was evaluated. Selective and general caspase inhibitors (4 mg/kg i.p.) were administered immediately after glycerol injection in a more severe form of the disease (glycerol 7 ml/kg). Finally, the effect of pan-caspase inhibitor (4 mg/kg) was analyzed when the peptide or vehicle were administered 12 h after the induction of Gly-ARF (5 ml/kg).
Renal function studies
Rats were expanded with water (10% body weight) by gavage and 2 h spontaneously voided urine was collected. At the end of urine collection, blood was drawn through cardiac puncture. Serum urea, creatinine, and urinary creatinine were measured by automated analyzer (Cobas-Mira, Roche, Basel, Switzerland). Creatinine clearance was calculated and normalized to 100 g body weight.
Histological analysis
Acute tubular necrosis. Kidneys were harvest, fixed in 10% formalin, and embedded in paraffin. Longitudinal cuts (4 mm) of the mid portion of the kidneys were stained with hematoxilin and eosin. The number of totally necrotic and desquamated tubules (absence of nucleus) was quantified in 15 random cortical HPD ( Â 400) for each rat.
TUNEL staining. In situ detection of DNA fragmentation characteristic of apoptotic cells was performed using TUNEL method. Briefly, longitudinal sections of the embedded kidneys were dewaxed, and endogenous peroxidase was blocked in 3% peroxide hydrogen. The tissue was incubated with Proteinase K (Roche, Mannheim, Germany) 20 mg/ml for 15 min at room temperature, then rinsed in transferase (terminal deoxynucleotidyl transferase) buffer (30 mM Tris, 140 mM sodium cacodylate, 1 mM cobalt chloride, pH 7.2), incubated with terminal deoxynucleotidyl transferase (Amershan Biosciences, Piscataway, NJ) 1:50, and biotinylated deuridine triphosphate (Gibco, Grand Island, NY) 1:50 in terminal deoxynucleotidyl transferase buffer for 60 min at room temperature. Labeled nuclei were detected with Vectastain ABC (Vector Laboratories, Burlingame, CA, USA) incubation for 30 min developed by diaminobenzidine tetrahydrochloride (Dako, Carpinteria, CA, USA) as a substrate chromogen solution. Sections were counterstained with hematoxylin. Positive tubular cells were counted in 15 random HPF ( Â 400) in the cortex and 15 in the medulla.
Immunohistochemistry
Assessment of cellular proliferation by BrdU labeling. BrdU 100 mg/kg (Calbiochem, La Jolla, CA, USA) was injected intraperitoneally 1 h before killing, and the kidneys were fixed in 10% formalin and embedded in paraffin. Longitudinal sections of the mid-kidney were dewaxed, rehydrated, and placed in 2 N HCl at 311C for 20 min and 0.005% trypsin in phosphate-buffered saline (PBS) at 371C for 2 min for antigen retrieval. Slides were placed in 1% non-fat milk in PBS for 1 h to block nonspecific staining. Tissue sections were incubated in 1:50 dilution of 1% bovine serum albumin of monoclonal anti-BrdU antibody (Dako, Glostrup, Denmark) for 1.5 h at room temperature. After washing in PBS, a biotinylated secondary anti-mouse antibody (Dako, Glostrup, Denmark) prepared 1:200 dilution in 1% bovine serum albumin was applied for 1 h. To block endogenous peroxidase slides were incubated in 3% H 2 O 2 for 15 min. ABC reagent (Dako, Glostrup, Denmark) was applied to slides for 30 min followed by diaminobenzidine tetrahydrochloride (Dako, Carpinteria, CA, USA). Sections were counterstained with hematoxylin. The BrdU-positive tubular cells were scored in 12 randomly selected HPF ( Â 400) in the cortex and 12 fields in the medulla.
Macrophages. Slides were dewaxed and endogenous peroxidase blocked (3% H 2 O 2 ), antigen retrieving was accomplished by heating tissue at 931C in a microwave oven in 10 mM citrate buffer, pH 6 for 30 min. Primary anti-equine dermal-1 antibody 1:100 (Serotec, Oxford, UK) was incubated in humid camera for 1 h at room temperature, and biotinylated universal secondary antibody 1:400 (Novocastra, Newcatle, UK) was incubated for 30 min at room temperature. The reaction product was detected with ABC Kit (Dako, Glostrup, Denmark) and color developed with diaminobenzidine tetrahydrochloride (Dako, Carpinteria, CA, USA). Equine dermal-1 positive cells were counted in 12 randomly selected cortical and 12 medullar tubulointerstitial HPF ( Â 400).
T lymphocytes. Slides were dewaxed and endogenous peroxidase blocked (2% H 2 O 2 ), and then antigen retrieving was accomplished heating tissue at 931C for 1 min followed by 601C for 9 min in microwave oven in 10 mM citrate buffer, pH 6. Primary antibody (MAS010P -Monoclonal mouse anti-rat T lymphocytes, Accurate Medical, Wesbury, NY, USA) 1:50 was incubated with the tissue overnight at 41C. After PBS rinsing goat anti-mouse peroxidase conjugated secondary antibody (Novocastra, Newcastle, UK) diluted 1:200 was incubated at room temperature for 1 h. The color was developed with diaminobenzidine tetrahydrochloride (Dako, Carpinteria, CA, USA). MAS010P positive cells were counted in 12 randomly selected cortical and 12 medullar tubulointerstitial HPF ( Â 400).
IL-1b. Slides were dewaxed and endogenous peroxidase was blocked in 3% H 2 O 2 for 45 min. Antigenic retrieval in 10 mM citrate buffer pH 6 in microwave oven 901 for 30 min followed by PBS washing and blockage with normal goat serum for 30 min. Primary antibody to IL-1b (rabbit anti-rat, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) 1:100 was incubated in humid chamber at room temperature for 1 h followed by secondary biotinylated antibody (goat anti-rabbit, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) 1:400 for 30 min. The reaction product was detected with ABC Kit (Dako, Glostrup, Denmark) and color developed with diaminobenzidine tetrahydrochloride (Dako, Carpinteria, CA, USA). Fifteen random cortical HPF Â 400 were captured by computerized video microscopy. Using the software KS 300 Imaging System, Zeiss, the HPF was grid lined 10 Â 10 and the number of stained grid fields were counted in each HPF Â 400. The results are expressed as the percentage of positive grid fields.
IL-18. Slides were dewaxed and sections were washed three times for 5 min each in permeabilization solution, which consisted of PBS with 0.1% saponin, 0.1% bovine serum albumin, and 1% fetal calf serum. Endogenous peroxidase was blocked in 130 ml of permeabilization solution with 12 ml of 30% H 2 O 2 for 30 min and then treated with avidin and biotin blocking kit (Vector Laboratories, Burlingame, CA, USA) for 15 min. Goat anti-rat IL-18 antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) diluted 1:100 in permeabilization solution was added, and incubation was performed overnight at 41C. Nonspecific binding sites were blocked with rabbit serum (Dako, Glostrup, Denmark) diluted 1:10 in permeabilization solution. Secondary antibody (rabbit anti-goat, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) 1:100 dilution was added for 1 h. The reaction product was detected with ABC Kit (Dako, Glostrup, Denmark) and color developed with diaminobenzidine tetrahydrochloride (Dako, Carpinteria, CA, USA). In total, 10 cortical and 10 outer medullary HPF Â 400 were captured by computerized video microscopy and the same scoring method as for IL-1b was used.
Western immunoblot analyses
Kidney cortex fragments were homogenized at 41C in 2% SDS, 60 mM Tris-HCl, and 40 ml/ml cocktail protease inhibitors (Complete Mini, Roche, Mannheinn, Germany). The homogenized solution was centrifuged at 11 000 g at 41C for 10 min. A sample of the supernatant was used for protein quantification using Bradford method (Bio-Rad Laboratories, Hercules, CA, USA).
For IL-1b and IL-18 Western blotting, 50 mg of total protein in 5% glycerol, 0.03% bromophenol blue, and 10 mM dithiothreitol were loaded in 15% SDS-polyacrylamide gel and eletrophoresed in Laemmli solution. Molecular weight marker (Rainbow, Bio-Rad Laboratories, Hercules, CA, USA) was used as standard. Proteins were transferred onto nitrocellulose membranes in transfer buffer (50 mM Tris-HCl, pH 7, 380 mM glycine, 0.1% SDS, and 20% methanol). Nonspecific binding was blocked by incubating the membranes overnight at 41C in 3% bovine serum albumin in Tris-buffered saline with 0.1% Tween buffer. Primary rabbit anti-rat IL-1b antibody 1:1000 and goat anti-rat IL-18 1:200 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) were incubated with the membrane for 1 h at room temperature. After washing with Tris-buffered saline with 0.1% Tween, secondary antibody for IL-1b (goat anti-rabbit 1:50000) and for IL-18 (donkey anti-goat 1:5000, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) were incubated for 1 h at room temperature. Immunoreactive bands were visualized using the enhanced chemiluminescence method (Pierce Chemical, Rockport, IL, USA).
For p27 Kip1 Western blotting analysis, 60 mg of protein in 5% glycerol, 0.03% bromophenol blue and 10 mM dithiothreitol were loaded into 15% SDS polyacrylamide gel. Proteins were transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) in transfer buffer (50 mM Tris-HCl, pH 7, 380 mM glycine, 0.1% SDS, and 20% methanol). Nonspecific binding was blocked by incubating the membranes overnight at 41C in 5% nonfat milk in PBS with 0.1% Tween-20. For the detection of p27 Kip1 , a mouse anti-rat monoclonal anti-p27
Kip1 antibody (Transduction Laboratories, Lexington, KY, USA) was used at a dilution of 1:1000 and was incubated with the membranes for 1 h at room temperature. The blots were subsequently incubated with horseradish peroxidaseconjugated goat anti-mouse secondary antibody 1:20 000 (New England Biolabs, Beverly, MA, USA). Immunoreactive bands were visualized using the enhanced chemiluminescence method (Pierce Chemical, Rockport, IL, USA).
Statistical analysis
Data are presented as mean7s.e.m. Data were compared using analysis of variance-Student-Newman-Keuls (biochemistry) and Mann-Witney or Kruskal-Wallis-Dunn. P-value less than 0.05 was considered significant.
